Project description:Gene expression profiling reveals a potential role of TCQA in neuronal and pigment cell differentiation of hAECs. hAECs were isolated from discarded term placenta and were treated with 20 μM TCQA for seven days. Microarray gene expression profiling was conducted for biological replicates of TCQA-treated (T7) and untreated control cells on day 0 (D0) and day 7 (D7).
Project description:Gene expression profiling reveals a potential role of TCQA in the upregulation of hair pigmentation in mice hair shaft Skin was isolated from mice dorsal part treated with MilliQ and TCQA; Microarray gene expression profiling was conducted.
Project description:Gene expression profiling reveals a potential effect of minoxdil and TCQA in stimulating hair growth in 2D cultered dermal papilla cells. HFDPCs were human primary cells line, treated with 0,1 µM minoxidil and 10 µM TCQA for 48 h. Microarray gene expression profiling was conducted for three biological replicates
Project description:Gene expression profiling reveals a potential higher effect of minoxdil and TCQA in stimulating hair growth in 3D cultered dermal papilla cells. HFDPCs were human primary cells line, treated with 0,1 µM minoxidil and 10 µM TCQA for 48 h. Microarray gene expression profiling was conducted for three biological replicates
Project description:Gene expression profiling reveals a potential role of Verbenalin in neural induction and neuronal differentiation of hAECs. hAECs were isolated from discarded term placenta and were treated with 20 μM verbenalin for seven days. Microarray gene expression profiling was conducted for biological replicates of RA-treated (T7) and untreated control cells on day 0 (D0) and day 7 (D7).
Project description:Gene expression profiling reveals a potential role of rosmarinic acid in neural induction and neuronal differentiation of hAECs. hAECs were isolated from discarded term placenta and were treated with 20 μM RA for seven days. Microarray gene expression profiling was conducted for biological replicates of RA-treated (T7) and untreated control cells on day 0 (D0) and day 7 (D7).